Sponsor Dossier
LEO Pharma
Sponsor Dossier for LEO Pharma. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ADVANTAN
- Brand: ANZUPGO
- Brand: DAIVOBET
- Brand: DAIVONEX
- Brand: ENSTILAR
- Brand: FINACEA
- Brand: FUCIDIN
- Brand: KLARVANTA
About
LEO Pharma is an Australian Private Company with ABN 72 147 880 617, registered in Queensland and currently active.
Portfolio
LEO Pharma holds 11 brands on the ARTG, of which 9 are indexable. Eight brands have Product Information on file. Four brands have PBAC outcomes on record and three brands have AusPARs on record.
Therapeutic focus —
Dermatology: 10 brands — Infectious Disease: 1 brand
Regulatory activity
LEO Pharma's latest PBAC outcome was recorded on 1 November 2025, with four brands holding PBAC outcomes. The latest AusPAR was issued on 27 August 2025, with three brands holding AusPARs on record.